Zai Lab Ltd (ZLAB)
Zai Lab Ltd (ZLAB) from its SEC filings: 2025 revenue $457.2 million (+15% vs the year before), net margin -38%, free cash flow -$158.9 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $457.2 million |
| Revenue growth | +15% |
| Net income | -$175.5 million |
| Net margin | -38.4% |
| Free cash flow | -$158.9 million |
| Diluted EPS | $-0.16 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -3% |
| Cash | $607.5 million |
| Share count, 1 year | +30% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.